Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials

about

Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials

Item

http://www.wikidata.org/entity/Q36285087

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Methodological challenges in a ...... imer's disease clinical trials

@ast

Methodological challenges in a ...... imer's disease clinical trials

@en

type

Item

label

Methodological challenges in a ...... imer's disease clinical trials

@ast

Methodological challenges in a ...... imer's disease clinical trials

@en

prefLabel

Methodological challenges in a ...... imer's disease clinical trials

@ast

Methodological challenges in a ...... imer's disease clinical trials

@en

P1476

Methodological challenges in a ...... imer's disease clinical trials

@en

P2093

Catherine Reed

http://www.w3.org/2001/XMLSchema#string

Howard Fillit

http://www.w3.org/2001/XMLSchema#string

Jonathan Kurlander

http://www.w3.org/2001/XMLSchema#string

Kristin Kahle-Wrobleski

http://www.w3.org/2001/XMLSchema#string

Mark Belger

http://www.w3.org/2001/XMLSchema#string

P2860

Forecasting the global burden of Alzheimer’s disease

“Mini-mental state”

Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases

EuroQol--a new facility for the measurement of health-related quality of life

The Clinical Dementia Rating (CDR): current version and scoring rules

Clinical features associated with costs in early AD: baseline data from the Predictors Study.

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.

P2888

s10198-014-0648-7

P304

995-1004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10198-014-0648-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269721727

http://www.w3.org/2001/XMLSchema#string

P698

25410743

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4646926

http://www.w3.org/2001/XMLSchema#string